VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

AMERIPRISE FINANCIAL INC's Holding History (CIK: 0000820027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 103,955 Value ($000) $1,167 Avg Close — Range —
Q1 2025
Shares 46,448 Value ($000) $212 Avg Close — Range —
Q4 2024
Shares 258,873 Value ($000) $1,460 Avg Close — Range —
Q3 2024
Shares 226,056 Value ($000) $1,094 Avg Close — Range —
Q2 2024
Shares 179,418 Value ($000) $876 Avg Close — Range —
Q1 2024
Shares 99,960 Value ($000) $1,327 Avg Close — Range —
Q4 2023
Shares 103,673 Value ($000) $1,445 Avg Close — Range —
Q3 2023
Shares 62,030 Value ($000) $823 Avg Close — Range —
Q2 2023
Shares 48,022 Value ($000) $900 Avg Close — Range —
Q1 2023
Shares 57,060 Value ($000) $823 Avg Close — Range —
Q4 2022
Shares 41,294 Value ($000) $799 Avg Close — Range —
Q3 2022
Shares 43,609 Value ($000) $1,498 Avg Close — Range —
Q2 2022
Shares 41,715 Value ($000) $637 Avg Close — Range —
Q1 2022
Shares 31,253 Value ($000) $713 Avg Close — Range —
Q4 2021
Shares 27,998 Value ($000) $1,032 Avg Close — Range —
Q3 2021
Shares 28,608 Value ($000) $1,345 Avg Close — Range —
Q2 2021
Shares 26,282 Value ($000) $1,583 Avg Close — Range —